Skip to main content
SpringerLink
Log in

Atezolizumab

Hepatitis and thrombocytopenia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tsukita Y, et al. Immunotherapy-related hepatitis and thrombocytopaenia induced by the very low dose of only 90 mg of atezolizumab. European Journal of Cancer 133: 22-24, Jul 2020. Available from: URL: http://doi.org/10.1016/j.ejca.2020.04.008

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Atezolizumab. Reactions Weekly 1809, 55 (2020). https://doi.org/10.1007/s40278-020-79839-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-79839-5

Search

Navigation